OXA-51-like β-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii
Open Access
- 1 March 2008
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 14 (3), 268-275
- https://doi.org/10.1111/j.1469-0691.2007.01919.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Identification of widespread, closely related Acinetobacter baumannii isolates in Portugal as a subgroup of European clone IIClinical Microbiology & Infection, 2007
- Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studiesCritical Care, 2006
- OXA β-lactamases in Acinetobacter: the story so farJournal of Antimicrobial Chemotherapy, 2005
- Contribution of Acquired Carbapenem-Hydrolyzing Oxacillinases to Carbapenem Resistance in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2005
- Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from ArgentinaClinical Microbiology & Infection, 2005
- Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitalsResearch in Microbiology, 2004
- Building Communication Networks: International Network for the Study and Prevention of Emerging Antimicrobial Resistance (INSPEAR)Emerging Infectious Diseases, 2001
- Endemic Carbapenem-Resistant Acinetobacter Species in Brooklyn, New York: Citywide Prevalence, Interinstitutional Spread, and Relation to Antibiotic UsageClinical Infectious Diseases, 2000
- Sequence Analysis of ARI-1, a Novel OXA β-Lactamase, Responsible for Imipenem Resistance in Acinetobacter baumannii 6B92Antimicrobial Agents and Chemotherapy, 2000
- Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological featuresClinical Microbiology Reviews, 1996